Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through video calls and online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
If signs and symptoms suggest you may have chronic myelomonocytic leukemia (CMML), the doctors will look at cells from your blood and bone marrow to confirm this diagnosis.
The complete blood count (CBC) measures different cells in the blood, such as the red blood cells, the white blood cells, and the platelets. The CBC is often done with a differential count (or “diff”), which is a count of the different types of white blood cells in the blood sample. In a blood smear, some of the blood is put on a slide to see how the cells look under the microscope.
People with CMML have higher numbers of monocytes, (at least 1,000 per mm3). Sometimes they have low numbers of other white blood cells. They may have shortages of red blood cells and blood platelets, as well.
Some patients have a small number of monoblasts in the blood. Monoblasts are the early, immature cells that grow and divide to make mature monocytes. Normally, these cells are only found in the bone marrow. It's never normal to see blasts in the blood, and it's often a sign of a bone marrow problem.
Blood cells from CMML patients may also have certain changes in size, shape, or other features that can be seen under the microscope. Blood abnormalities may suggest CMML, but an exact diagnosis cannot be made without looking at and testing cells taken from the bone marrow.
Other blood tests may be done to check for other possible causes of low blood counts, such as low levels of vitamin B12 and folate. Tests may also be done to look for other causes of a high white blood cell count, such as an infection.
Samples of your bone marrow are taken by bone marrow aspiration and biopsy for testing. The samples are usually taken from the back of the pelvic (hip) bone. These tests are used to diagnosis and classify the type of blood cancer you have. They may be repeated later to see if treatment is working or to see if the CMML is transforming into an acute leukemia.
For bone marrow aspiration, you lie flat on a table (either on your side or on your belly). After cleaning the skin over the hip, the surface of the bone is numbed with local anesthetic. A very thin needle is used to put in the numbing drug, which may cause a brief stinging or burning sensation. A long, hollow needle is then put into the bone and a syringe is used to suck out a small amount of liquid bone marrow (about 1 teaspoon). Even with the anesthetic, most patients still have some brief pain when the marrow is removed.
A bone marrow biopsy is usually done right after the aspiration. A small core of bone and marrow (about 1/16 inch in diameter and 1/2 inch long) is removed with a wider needle that's twisted as it's pushed into the hip bone. The biopsy may also cause some brief pain. Once the biopsy is done, pressure will be held to help prevent bleeding and bruising.
A pathologist (a doctor specializing in the diagnosis of diseases using laboratory tests) examines the bone marrow samples under a microscope. A hematologist (a doctor specializing in medical treatment of diseases of the blood and blood-forming tissues) or an oncologist (a doctor specializing in medical treatment of cancer) usually looks at the samples too.
The doctors will look at the types and number of blood-forming cells in the bone marrow aspirate and biopsy. They will also check to see if the bone marrow shows signs of infections, cancer cells, or other disorders. They will examine the size and shape of the cells and determine whether the red cells contain iron particles or the other cells contain granules (microscopic collections of enzymes and other chemicals that help white blood cells to fight infections).
Tests will be done to measure the percentage of marrow cells that are blasts. This is very important. Blasts are very early (immature) cells that are made by bone marrow stem cells. Over time, blasts mature into normal blood cells. But in CMML, some of the blasts do not mature properly, so there may be too many blasts and not enough mature cells. For a diagnosis of CMML, there must be less than 20% blasts in the bone marrow. A patient who has more than 20% blasts in the bone marrow has acute leukemia.
This test looks at the chromosomes inside the cells. DNA in human cells is packed into chromosomes. Each cell should have 46 chromosomes (23 pairs). Chromosome changes or abnormalities are fairly common in CMML. Sometimes pieces of chromosomes or even whole chromosomes are missing. CMML cells may also have extra copies of all or part of some chromosomes. Chromosome translocations may also be seen. This is where parts of chromosomes trade places with each other.
Chromosome testing can also help the doctors be sure that the problem isn’t a different leukemia, called chronic myeloid leukemia or CML. The leukemia cells in CML often contain an abnormal chromosome caused by a certain translocation. This is called the Philadelphia chromosome or BCR/ABL fusion. If the Philadelphia chromosome is present, the diagnosis is CML, not CMML. CMML also does not have changes in certain genes, called PDGFRA and PDGFRB. If these changes are present the problem might be a different myeloproliferative disorder.
Cytogenetic testing can take several weeks because the bone marrow cells need time to grow in laboratory dishes before the chromosomes can be seen with a microscope. The results of cytogenetic testing are written in a way that describes which chromosome changes are present. For instance:
These are other bone marrow tests that help the doctor diagnose CMML and rule out other blood diseases:
These tests can be done on cells besides bone marrow cells, such as cells from the blood.
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
National Cancer Institute. Myelodysplastic/Myeloproliferative Neoplasms Treatment (PDQ) - Patient Version. August 12, 2015.
Nazha A, Prebet T, Gore S, Zeidan AM. Chronic myelomonocytic leukemia: Are we finally solving the identity crisis? Blood Rev. 2016;30(5):381-388.
Patnaik MM, Tefferi A. Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management. Am J Hematol. 2016;91(6):631-642.
Last Revised: October 24, 2017
Donate now so we can continue to provide access to critical cancer information, resources, and support to improve lives of people with cancer and their families.